NO20073011L - Lipase-inhibitorer - Google Patents

Lipase-inhibitorer

Info

Publication number
NO20073011L
NO20073011L NO20073011A NO20073011A NO20073011L NO 20073011 L NO20073011 L NO 20073011L NO 20073011 A NO20073011 A NO 20073011A NO 20073011 A NO20073011 A NO 20073011A NO 20073011 L NO20073011 L NO 20073011L
Authority
NO
Norway
Prior art keywords
inhibitors
lipase inhibitors
lipases
prototype
methods
Prior art date
Application number
NO20073011A
Other languages
English (en)
Inventor
Hung-Sen Lai
William W Bachovchin
Daniel Phillip O'connell
Original Assignee
Tufts College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tufts College filed Critical Tufts College
Publication of NO20073011L publication Critical patent/NO20073011L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Foreliggende oppfinnelse vedrører inhibitorer av lipaser, så som inhibitorer av endotellipase, samt farmasøytiske sammensetninger derav og fremgangsmåter for anvendelse av slike inhibitorer. Prototypen til disse inhibitorene har en lipofil del og et elektrofilt sete.
NO20073011A 2004-11-12 2007-06-12 Lipase-inhibitorer NO20073011L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62747604P 2004-11-12 2004-11-12
PCT/US2005/041022 WO2006053250A2 (en) 2004-11-12 2005-11-14 Lipase inhibitors

Publications (1)

Publication Number Publication Date
NO20073011L true NO20073011L (no) 2007-08-08

Family

ID=36337276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073011A NO20073011L (no) 2004-11-12 2007-06-12 Lipase-inhibitorer

Country Status (11)

Country Link
US (2) US20090209492A1 (no)
EP (1) EP1824861A2 (no)
JP (1) JP2008519853A (no)
KR (1) KR20070086076A (no)
CN (1) CN101356179A (no)
AU (1) AU2005304318A1 (no)
BR (1) BRPI0517840A (no)
CA (1) CA2586479A1 (no)
IL (1) IL183129A0 (no)
NO (1) NO20073011L (no)
WO (1) WO2006053250A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
WO2009029317A2 (en) * 2007-06-08 2009-03-05 Georgia State University Research Foundation, Inc. Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
TW201000107A (en) 2008-04-09 2010-01-01 Infinity Pharmaceuticals Inc Inhibitors of fatty acid amide hydrolase
US8957219B2 (en) 2008-10-17 2015-02-17 Shionogi & Co., Ltd. Acetic acid amide derivative having inhibitory activity on endothelial lipase
AU2010234445A1 (en) 2009-04-07 2011-11-03 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
WO2010118159A1 (en) 2009-04-07 2010-10-14 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
ATE555721T1 (de) * 2009-04-23 2012-05-15 Hoffmann La Roche Verfahren und gerät zur ermittlung von empfehlungen für wirkstoffdosierungen anhand von messserien zumindest eines physiologischen parameters eines patienten
CN102753545A (zh) 2009-12-15 2012-10-24 盐野义制药株式会社 具有血管内皮脂酶抑制活性的噁二唑衍生物
RU2569061C2 (ru) 2010-02-03 2015-11-20 Инфинити Фармасьютикалз, Инк. Ингибиторы амид-гидролазы жирных кислот
US20130079305A1 (en) * 2010-05-31 2013-03-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. 3-substituted vinylboronates and uses thereof
CN105806967B (zh) * 2014-12-31 2018-02-06 广州朗圣药业有限公司 依折麦布关键中间体4‑[[(4‑氟苯基)亚胺]甲基]‑苯酚的分析方法
CN105572252A (zh) * 2015-12-18 2016-05-11 武汉武药科技有限公司 一种分析/分离依折麦布(r,r,s)型的光学异构体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA58494C2 (uk) * 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
JP3456511B2 (ja) * 1997-01-27 2003-10-14 昭和電工株式会社 陰イオンの分析法及び陰イオン分析セット
JPH10210999A (ja) * 1997-01-29 1998-08-11 Eiken Chem Co Ltd エステル加水分解酵素活性の阻害方法
TW458977B (en) * 1997-04-16 2001-10-11 Abbott Lab 6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
US6858592B2 (en) * 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity

Also Published As

Publication number Publication date
AU2005304318A1 (en) 2006-05-18
EP1824861A2 (en) 2007-08-29
WO2006053250A2 (en) 2006-05-18
WO2006053250A3 (en) 2008-07-10
US20090209492A1 (en) 2009-08-20
BRPI0517840A (pt) 2008-10-21
KR20070086076A (ko) 2007-08-27
CA2586479A1 (en) 2006-05-18
US20120101062A1 (en) 2012-04-26
IL183129A0 (en) 2008-04-13
JP2008519853A (ja) 2008-06-12
CN101356179A (zh) 2009-01-28

Similar Documents

Publication Publication Date Title
NO20073011L (no) Lipase-inhibitorer
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
NO20074807L (no) Fast farmasoytisk doseringsformulering
FR2883179B1 (fr) Comprime enrobe
NO20083011L (no) Modulatorer av muskarine receptorer
DK1819353T3 (da) Sammensætning til proteasomhæmning
AR056292A1 (es) Sistema y metodo para operar uno o mas dispensadores de combustible
EA200802008A1 (ru) Фармацевтические композиции
NO20070785L (no) Sammensetninger for levering av svaert vannloselige medikamenter.
CR9851A (es) Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas
CR10530A (es) Anticuerpos anti-dlla4 y metodos que los usan
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
NO20071078L (no) Antivirale forbindelser
NO20070866L (no) Antivirale forbindelser.
NO20075693L (no) Modulerende forbindelser av indolamin-2,3-dioksygenase og fremgangsmater for anvendelse av samme
NO20082170L (no) Forbedret testosterongel og fremgangsmate til anvendelse
NO20093009L (no) Kondensert ring heterocykel kinase modulatorer
EA200971051A1 (ru) Ингибиторы p70 s6 киназы
NO20070908L (no) Sammensmeltede ringheterocykelkinasemodulatorer
NO20071823L (no) Testosterongeler omfattende polypropylenglykol som gjennomtrengningsforsterker
NO20071272L (no) Modulatorer av muskarine reseptorer.
MA38828A1 (fr) Anticorps dirigés contre l'inhibiteur des activateurs du plasminogène de type 1 (pai-1) et leurs utilisations
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
DK1635783T5 (da) Farmaceutiske sammensætninger omfattende fentanyl til intranasal levering
NO20084006L (no) Modulatorer av muskarinreseptorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application